• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Therapeutic approach to hepatitis C by regulation of apoptosis-related gene

Research Project

Project/Area Number 08457167
Research Category

Grant-in-Aid for Scientific Research (B)

Allocation TypeSingle-year Grants
Section一般
Research Field Gastroenterology
Research InstitutionOsaka University

Principal Investigator

HAYASHI Norio  Osaka University Medical School, Associate Professor, 医学部, 助教授 (00144478)

Co-Investigator(Kenkyū-buntansha) KANTO Tatsuya  Osaka University Hospital, Medical Staff, 医学部・附属病院, 医員
MITA Eiji  Osaka University Hospital, Medical Staff, 医学部・附属病院, 医員
TAKEHARA Tetsuo  Osaka University Hospital, Medical Staff, 医学部・附属病院, 医員
KASAHARA Akinori  Osaka University Hospital, Associate Professor, 医学部・附属病院, 助教授 (70214286)
Project Period (FY) 1996 – 1997
Project Status Completed (Fiscal Year 1997)
Budget Amount *help
¥8,700,000 (Direct Cost: ¥8,700,000)
Fiscal Year 1997: ¥3,000,000 (Direct Cost: ¥3,000,000)
Fiscal Year 1996: ¥5,700,000 (Direct Cost: ¥5,700,000)
KeywordsHepatitis C Virus / Apoptosis / Fas Antigen / Soluble Fas Antigen / B7-1 (CD80) / Cytotoxic T Lymphocyte / HLA / TGF-beta1 / リボザイム / TGF-α1 / C型肝炎ウイルス / 遺伝子導入 / セカンドシグナル / B7-1遺伝子 / B7-2遺伝子 / HLAクラスI / インターフェロン
Research Abstract

Cytotoxic T lymphocytes (CTL) play an important role in liver cell injury by hepatitis C virus (HCV) infection. We demonstrated that liver-infiltrating CD8 positive lymphocytes and natural killer cells expressed the functional Fas ligand. On the other hand, B7/BB-1 was strongly expressed in the cytoplasm of hepatocytes of HCV-infected liver. B7/BB-1-positive cells accompanied liver-infiltrating lymphocytes and were detected near HCV core antigen-and HLA class I-positive cells. B7/BB-1 expression was closely correlated with the activity of viral hepatitis. These findings suggest that B7/BB-1 expression by hepatocytes may be induced by HCV infection and may trigger generation and activation of CTL,which may cause damage to HCV-infected HLA class I-expressing hepatocytes via Fas antigen.
We measured the serum level of soluble Fas antigen (sFas) in patients with chronic hepatitis C and healthy volunteers. The serum sFas level was significantly higher in chronic hepatitis C patients than in … More healthy volunteers. It was also correlated with the expression level of Fas in hepatocytes and the severity of liver inflammation. Thus it may serve as a novel indicator for the activity of liver inflammation.
When HLA typing was tested among HCV-infected individuals, extended haplotypes including class I B54 are closely associated with the progression of liver injury, whereas extended haplotypes including class II DRB1^*1302-DQB1^*0604 are associated with low hepatitis activity. Thus the host factors as well as viral factors may determine the activity of CTL.
We showed that endogeneous TGF-beta1 block the induction of HCV-specific CTL and their cytolytic activity. By exvivo cell system, we demonstrated that the appropriate does of IL-2 and addition of anti-TGF-beta1 can induce the high cytotoxicity of CTL.The high activity was also introduced by using dendritic cells as antigen-presenting cells.
In summary, cytotoxic activity of CTL via Fas system plays a dominat role in liver cell damage by HCV infection. Some cytokines such as TGF-beta1 can modulate the CTL activity and regulate liver apoptosis. Less

Report

(3 results)
  • 1997 Annual Research Report   Final Research Report Summary
  • 1996 Annual Research Report
  • Research Products

    (26 results)

All Other

All Publications (26 results)

  • [Publications] Takehara T, et al.: "In vivo gene transfer and expression in rat stomach by submucosal injection of plasmid DNA." Human Gene Therapy. 7. 589-593 (1996)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1997 Final Research Report Summary
  • [Publications] Yuki N, et al.: "Quantitative analysis of antibody to hepatitis C virus envelope 2 glycoprotein in patients with chronic hepatitis C virus infection." Hepatology. 23. 947-952 (1996)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1997 Final Research Report Summary
  • [Publications] Mochizuki K, et al.: "B7/BB-1 expression and hepatitis activity in liver tissues of patients with chronic hepatitis C." Hepatology. 25. 713-718 (1997)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1997 Final Research Report Summary
  • [Publications] Tatsumi T, et al.: "Expression of costimulatory molecules B7-1(CD80)and B7-2(CD86)on human hepatocellular carcinoma." Hepatology. 25. 1108-1114 (1997)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1997 Final Research Report Summary
  • [Publications] Kuzushita N, et al.: "Influence of HLA haplotypes on the clinical courses of individuals infected with hepatitis C virus." Hepatology. 27. 240-244 (1998)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1997 Final Research Report Summary
  • [Publications] Kasahara A, et al.: "Risk factors for hepatocellular carcinoma and its incidence after interferon treatment in patients with chronic hepatitis C." Hepatology. (in press).

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1997 Final Research Report Summary
  • [Publications] Takehara, T,Hayashi N,Yamamoto M,et al.: "In vivo gene transfer and expression in rat stomach by submucosal injection of plasmid DNA." Human Gene Therapy. 7. 589-593 (1996)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1997 Final Research Report Summary
  • [Publications] Yuki N,Hayashi N,Kasahara A,et al.: "Quantitative analysis of antibody to hepatitis C virus envelope 2 glycoprotein in patients with chronic hepatitis C virus infection." Hepatology. 23. 947-952 (1996)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1997 Final Research Report Summary
  • [Publications] Yuki N,Hayashi N,Moribe T,et al.: "Relation of disease activity during chronic hepatitis C infection to complexity of hypervariable region 1 quasispecies." Hepatology. 25. 439-444 (1997)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1997 Final Research Report Summary
  • [Publications] Mochizuki K,Hayashi N,Katayama K,et al.: "B7/BB-1 expression and hepatitis activity in liver tissues of patients with chronic hepatitis C." Hepatology. 25. 713-718 (1997)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1997 Final Research Report Summary
  • [Publications] Tatsumi T,Takehara T,Katayama K,et al.: "Expression of costimulatory molecules B7-1 (CD80) and B7-2 (CD86) on human hepatocellular carcinoma." Hepatology. 25. 1108-1114 (1997)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1997 Final Research Report Summary
  • [Publications] Kuzushita N,Hayashi N,Moribe T,et al.: "Influence of HLA haplotypes on the clinical courses of individuals infected with hepatitis C virus." Hepatology. 27. 240-244 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1997 Final Research Report Summary
  • [Publications] Kasahara A,Hayashi N,Mochizuki K,et al.: "Risk factors for hepatocellular carcinoma and its incidence after interferon treatment in patients with chronic hepatitis C." Hepatology. ( in press).

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1997 Final Research Report Summary
  • [Publications] Takehara T,Hayashi N,Mita E,et al.: "Delayd Fas-mediated hepatocyte apoptosis during liver regeneration in mice." Hepatology. ( in press).

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1997 Final Research Report Summary
  • [Publications] Yuki N, et al.: "Relation of disease activity during chronic hepatitis C infection to complexity of hypervariable region 1 quasispecies." Hepatology. 25. 439-444 (1997)

    • Related Report
      1997 Annual Research Report
  • [Publications] Mochizuki K, et al.: "B7/BB-1 expression and hepatitis activity in liver tissues of patients with chronic hepatitis C." Hepatology. 25. 713-718 (1997)

    • Related Report
      1997 Annual Research Report
  • [Publications] Tatsumi T, et al.: "Expression of costimulatory molecules B7-1 (CD80) and B7-2 (CD86) on human hepatocellular carcinoma." Hepatology. 25. 1108-1114 (1997)

    • Related Report
      1997 Annual Research Report
  • [Publications] Kuzushita N, et al.: "Influence of HLA haplotypes on the clinical courses of individuals infected with hepatitis C virus." Hepatology. 27. 240-244 (1997)

    • Related Report
      1997 Annual Research Report
  • [Publications] Kasahara A, et al.: "Risk factors for hepatocellular carcinoma and its incidence after interferon treatment in patients with chronic hepatitis C." Hepatology. (in press).

    • Related Report
      1997 Annual Research Report
  • [Publications] Takehara T.et al.: "Delayed Fas-mediated hepatocyte apoptosis during liver regeneration in mice." Hepatology. (in press).

    • Related Report
      1997 Annual Research Report
  • [Publications] Hagiwara H,et al.: "Long-term biochemical and virological response to natural interferon alpha in patients with chronic hepatitis C." Digestive Diseases and Sciences. 41. 1001-1007 (1996)

    • Related Report
      1996 Annual Research Report
  • [Publications] Kanto T,et al.: "Low expression of erythrocyte complement receptor type 1 in chronic hepatitis C patients." Journal of Medical Virology. 50. 126-134 (1996)

    • Related Report
      1996 Annual Research Report
  • [Publications] Hagiwara H,et al.: "Ketreatment with 24-week course of interferon alpha for patients with chronic hepatitis C." International Hepatology Communications. 5. 135-142 (1996)

    • Related Report
      1996 Annual Research Report
  • [Publications] Suzuki K,et al.: "Expression of vascular permeability factor/vascular endothelial growth factor in human hepatocellular carcinoma." Cancer Research. 56. 3004-3009 (1996)

    • Related Report
      1996 Annual Research Report
  • [Publications] Hagiwara H,et al.: "Treatment with recombinant interferon alpha 2a for patients with chronic hepatitis C : Predictive factors for biochemical and virological respense." Scandinavian Journak of Gastroenterology. 31. 1021-1026 (1996)

    • Related Report
      1996 Annual Research Report
  • [Publications] Kanazawa Y,et al.: "Hammerhead ribozyme-mediated inhibition of telomerase activity in extracts of human hepatocellular carcinoma cells." Biochemical and Biophysical Research Communications. 225. 570-576 (1996)

    • Related Report
      1996 Annual Research Report

URL: 

Published: 1996-04-01   Modified: 2025-11-20  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi